VALIDOGEN, formerly known as VTU Technology, is a leading Austrian contract research and development company specializing in Pichia pastoris protein expression. They offer UNLOCK PICHIA, the most versatile and comprehensive toolbox for recombinant peptide and protein production. VALIDOGEN develops high-performance expression strains and economically viable processes for biopharmaceuticals, enzymes, and other recombinant proteins.

With a diverse set of expression tools and strategies, VALIDOGEN maximizes protein expression through their proprietary AOX1 promoter library, 2nd generation promoter variants, and time-controlled co-expression of helper proteins. Their unique microscale cultivation and screening abilities allow for the fast and reliable identification of the best performing genetic arrangement. VALIDOGEN’s UNLOCK PICHIA technology addresses challenges from transcription to secretion, enabling the expression of more complex proteins while maintaining high yield and quality.

They also offer customized production strains, bioreactor cultivation, protein purification, and enzyme engineering services. Whether in the pharmaceutical, diagnostics, food and feed, or chemical industries, VALIDOGEN provides tailor-made solutions for their customers' protein expression needs